Lv3
320 积分 2022-05-29 加入
Taking immunogenicity assessment of therapeutic proteins to the next level
6小时前
待确认
Discovery and Investigation ofO-Xylosylation in Engineered Proteins Containing a (GGGGS)nLinker
6小时前
已完结
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer
5天前
已完结
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling
1个月前
已完结
Cloning of DNA oligo pools for in vitro expression
1个月前
已完结
Emerging role of anti‐IL23 in the treatment of psoriasis: When humanized is very promising
2个月前
已完结
IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis
2个月前
已完结
P001 The biomarker profile of PTG-200, an oral peptide antagonist of IL-23 receptor, tracks with efficacy in a preclinical model of IBD
2个月前
已完结
Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease
2个月前
已完结
AIntibody: an experimentally validated in silico antibody discovery design challenge
2个月前
已完结
皖公网安备34019202002308
